Shares of Vitalhub Corp. (TSE:VHI – Get Free Report) have received an average rating of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is C$13.14.
Several brokerages have recently weighed in on VHI. Raymond James Financial cut their price objective on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. ATB Cormark Capital Markets cut their price target on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. National Bank Financial cut their price target on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a report on Wednesday. Finally, Scotiabank cut their price target on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th.
Get Our Latest Stock Analysis on Vitalhub
Vitalhub Price Performance
Vitalhub (TSE:VHI – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 earnings per share for the quarter. The business had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. Analysts expect that Vitalhub will post 0.2296467 earnings per share for the current fiscal year.
Insider Activity at Vitalhub
In other Vitalhub news, Director Anthony Pius Shen purchased 7,000 shares of the business’s stock in a transaction that occurred on Monday, March 30th. The shares were purchased at an average price of C$7.11 per share, for a total transaction of C$49,770.00. Following the completion of the acquisition, the director owned 12,470 shares of the company’s stock, valued at approximately C$88,661.70. This represents a 127.97% increase in their position. Also, Director Francis Nelson Shen purchased 439,600 shares of the business’s stock in a transaction that occurred on Tuesday, March 24th. The stock was acquired at an average price of C$7.00 per share, for a total transaction of C$3,077,200.00. Following the acquisition, the director directly owned 588,300 shares of the company’s stock, valued at C$4,118,100. This trade represents a 295.63% increase in their position. Insiders purchased 496,600 shares of company stock worth $3,476,470 in the last 90 days. 18.57% of the stock is currently owned by insiders.
Vitalhub Company Profile
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Stories
- Five stocks we like better than Vitalhub
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
